448 related articles for article (PubMed ID: 33951350)
21. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.
Yanai H; Kagramanova A; Knyazev O; Sabino J; Haenen S; Mantzaris GJ; Mountaki K; Armuzzi A; Pugliese D; Furfaro F; Fiorino G; Drobne D; Kurent T; Yassin S; Maharshak N; Castiglione F; de Sire R; Nardone OM; Farkas K; Molnar T; Krznaric Z; Brinar M; Chashkova E; Livne Margolin M; Kopylov U; Bezzio C; Bar-Gil Shitrit A; Lukas M; Chaparro M; Truyens M; Nancey S; Lobaton T; Gisbert JP; Saibeni S; Bacsúr P; Bossuyt P; Schulberg J; Hoentjen F; Viganò C; Palermo A; Torres J; Revés J; Karmiris K; Velegraki M; Savarino E; Markopoulos P; Tsironi E; Ellul P; Calviño Suárez C; Weisshof R; Ben-Hur D; Naftali T; Eriksson C; Koutroubakis IE; Foteinogiannopoulou K; Limdi JK; Liu E; Surís G; Calabrese E; Zorzi F; Filip R; Ribaldone DG; Snir Y; Goren I; Banai-Eran H; Broytman Y; Amir Barak H; Avni-Biron I; Ollech JE; Dotan I; Aharoni Golan M
J Crohns Colitis; 2022 Dec; 16(12):1882-1892. PubMed ID: 35895074
[TBL] [Abstract][Full Text] [Related]
23. Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials.
Beelen EMJ; Nieboer D; Arkenbosch JHC; Regueiro MD; Satsangi J; Ardizzone S; López-Sanromán A; Savarino E; Armuzzi A; Janneke van der Woude C; de Vries AC
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2741-2752.e6. PubMed ID: 34687970
[TBL] [Abstract][Full Text] [Related]
24. Crohn's disease management after intestinal resection: a randomised trial.
De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Gibson PR; Sparrow M; Leong RW; Florin TH; Gearry RB; Radford-Smith G; Macrae FA; Debinski H; Selby W; Kronborg I; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
Lancet; 2015 Apr; 385(9976):1406-17. PubMed ID: 25542620
[TBL] [Abstract][Full Text] [Related]
25. Tripterygium wilfordii Hook. f. versus azathioprine for prevention of postoperative recurrence in patients with Crohn's disease: a randomized clinical trial.
Zhu W; Li Y; Gong J; Zuo L; Zhang W; Cao L; Gu L; Guo Z; Li N; Li J
Dig Liver Dis; 2015 Jan; 47(1):14-9. PubMed ID: 25445405
[TBL] [Abstract][Full Text] [Related]
26. Prevention of postoperative recurrence of Crohn's disease.
van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB
J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
[TBL] [Abstract][Full Text] [Related]
27. Immediate prophylactic vs endoscopic or symptomatic-driven azathioprine treatment to prevent surgical recurrence after intestinal resection for Crohn's disease.
Guo Z; Cai X; Liu R; Gong J; Li Y; Cao L; Wang Z; Zhu W
Colorectal Dis; 2018 Sep; 20(9):O267-O276. PubMed ID: 30051962
[TBL] [Abstract][Full Text] [Related]
28. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
[TBL] [Abstract][Full Text] [Related]
29. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.
Mowat C; Arnott I; Cahill A; Smith M; Ahmad T; Subramanian S; Travis S; Morris J; Hamlin J; Dhar A; Nwokolo C; Edwards C; Creed T; Bloom S; Yousif M; Thomas L; Campbell S; Lewis SJ; Sebastian S; Sen S; Lal S; Hawkey C; Murray C; Cummings F; Goh J; Lindsay JO; Arebi N; Potts L; McKinley AJ; Thomson JM; Todd JA; Collie M; Dunlop MG; Mowat A; Gaya DR; Winter J; Naismith GD; Ennis H; Keerie C; Lewis S; Prescott RJ; Kennedy NA; Satsangi J;
Lancet Gastroenterol Hepatol; 2016 Dec; 1(4):273-282. PubMed ID: 28404197
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis.
De Cruz P; Kamm MA; Hamilton AL; Ritchie KJ; Krejany EO; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits S; Florin TH; Gibson PR; Debinski H; Gearry RB; Macrae FA; Leong RW; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Desmond PV
Aliment Pharmacol Ther; 2015 Oct; 42(7):867-79. PubMed ID: 26314275
[TBL] [Abstract][Full Text] [Related]
31. Intra-abdominal septic complications after ileocolic resection increases risk for endoscopic and surgical postoperative Crohn's disease recurrence.
Bachour SP; Shah RS; Rieder F; Qazi T; Achkar JP; Philpott J; Lashner B; Holubar SD; Lightner AL; Barnes EL; Axelrad J; Regueiro M; Click B; Cohen BL
J Crohns Colitis; 2022 Nov; 16(11):1696-1705. PubMed ID: 35705188
[TBL] [Abstract][Full Text] [Related]
32. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
Regueiro M; Feagan BG; Zou B; Johanns J; Blank MA; Chevrier M; Plevy S; Popp J; Cornillie FJ; Lukas M; Danese S; Gionchetti P; Hanauer SB; Reinisch W; Sandborn WJ; Sorrentino D; Rutgeerts P;
Gastroenterology; 2016 Jun; 150(7):1568-1578. PubMed ID: 26946343
[TBL] [Abstract][Full Text] [Related]
33. Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.
Baillet P; Cadiot G; Goutte M; Goutorbe F; Brixi H; Hoeffel C; Allimant C; Reymond M; Obritin-Guilhen H; Magnin B; Bommelaer G; Pereira B; Hordonneau C; Buisson A
World J Gastroenterol; 2018 Feb; 24(5):641-650. PubMed ID: 29434453
[TBL] [Abstract][Full Text] [Related]
34. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
[TBL] [Abstract][Full Text] [Related]
35. KONO-S Anastomosis Is Not Superior to Conventional Anastomosis for the Reduction of Postoperative Endoscopic Recurrence in Crohn's Disease.
Tyrode G; Lakkis Z; Vernerey D; Falcoz A; Clairet V; Alibert L; Koch S; Vuitton L
Inflamm Bowel Dis; 2023 Sep; ():. PubMed ID: 37776562
[TBL] [Abstract][Full Text] [Related]
36. Thiopurines prevented surgical recurrence in patients with Crohn's disease after intestinal resection: Strategy based on risk stratification.
Guo J; Chen BL; Chen ZH; Luo XP; Qiu Y; Zhang SH; Feng R; He Y; Zeng ZR; Song XM; Ben-Horin S; Mao R; Chen MH
J Gastroenterol Hepatol; 2018 Mar; 33(3):608-614. PubMed ID: 28804920
[TBL] [Abstract][Full Text] [Related]
37. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis.
Cañete F; Mañosa M; Pérez-Martínez I; Barreiro-de Acosta M; González-Sueyro RC; Nos P; Iglesias-Flores E; Gutiérrez A; Bujanda L; Gordillo J; Ríos León R; Casanova MJ; Villoria A; Rodríguez-Lago I; López Serrano P; García-Herola A; Ramírez-de la Piscina P; Navarro-Llavat M; Taxonera C; Barrio J; Ramos L; Navarro P; Benítez-Leiva O; Calafat M; Domènech E;
Clin Transl Gastroenterol; 2020 Aug; 11(8):e00218. PubMed ID: 32955190
[TBL] [Abstract][Full Text] [Related]
38. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry.
Cañete F; Mañosa M; Casanova MJ; González-Sueyro RC; Barrio J; Bermejo F; Nos P; Iglesias-Flores E; García-Planella E; Pérez-Calle JL; Vicente R; Vera M; Ramos L; Rivero M; De Francisco R; Montserrat A; Benítez O; Navarro P; Taxonera C; Hinojosa E; Márquez-Mosquera L; Navarro-Llavat M; Ramírez-de la Piscina P; Gomollón F; Rodríguez-Alonso L; Núñez-Alonso A; Fernández-Salazar L; Almela P; Ríos León R; De Castro L; Gisbert JP; Ricart E; Cabré E; Domènech E;
Inflamm Bowel Dis; 2019 Oct; 25(11):1862-1870. PubMed ID: 31006801
[TBL] [Abstract][Full Text] [Related]
39. Anti-TNFα agents are the best choice in preventing postoperative Crohn's disease: A meta-analysis.
Erős A; Farkas N; Hegyi P; Szabó A; Balaskó M; Veres G; Czakó L; Bajor J; Alizadeh H; Rakonczay Z; Mikó A; Habon T; Erőss B; Bérczi B; Sarlós P
Dig Liver Dis; 2019 Aug; 51(8):1086-1095. PubMed ID: 31278016
[TBL] [Abstract][Full Text] [Related]
40. Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.
Bayart P; Duveau N; Nachury M; Zerbib P; Gerard R; Branche J; Maunoury V; Wils P; Boruchowicz A; Boualit M; Laberenne JE; Manolache O; Desreumaux P; de Chambrun GP; Pariente B
Dig Dis Sci; 2016 Oct; 61(10):2986-2992. PubMed ID: 27401274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
